A t(5;12)(q33;p13) translocation is a recurrent chromosome abnormality in a subgroup of myeloid malignancies with features of both myeloproliferative disorders and myelodysplastic syndromes (MDSs). The molecular consequence of a t(5;12) is a fusion between the platelet-derived growth factor receptor-B gene on chromosome 5 and a novel ETS-like gene, TEL, on chromosome 12. We report on three patients with a t(5;12)(q33;p13) diagnosed as chronic myelomonocytic leukemia, and one case of a t(10;12)(q24;p13) in a progressive MDS, with eosinophilia and monocytosis. Involvement of the TEL gene in these chromosome translocations was investigated by fluorescence in situ hybridization (FISH) with cosmid probes containing selectively the 5′ end or 3′ end of TEL. Hybridization of these cosmids to the der(5)/der(10) or a der(12), respectively, demonstrated a rearrangement of TEL in both translocations, showing that the t(10;12) is a variant translocation of the t(5;12). Cloning of the fusion cDNA of one case of t(5;12) showed that the breakpoint occurred at the RNA level at exactly the same position as reported by Golub et al (Cell 77:307, 1994). In addition, the TEL gene on chromosome 12 could be localized between two probes previously mapped to 12p13, namely PRB1 and D12S178, leading to a better definition of the position of TEL in this chromosome region. Moreover, in the case involving chromosome 10, the breakpoint occurred between cKTN206 and cKTN312/LYT-10 at 10q24. Clinicohematological data in these studies as well as the restriction mapping of chromosomal breakpoints strongly suggest that (1) common features in MDSs involving the TEL gene are monocytosis and eosinophilia, (2) chromosomes other than no. 5 may be involved and at least a t(10;12)(q24;p13) variant chromosome translocation does exist in these MDSs, and (3) both standard and variant 12p/TEL translocations may be identified by FISH with appropriate probes.
Skip Nav Destination
ARTICLES|
May 15, 1995
TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13)
I Wlodarska,
I Wlodarska
Center for Human Genetics, University of Leuven, Belgium.
Search for other works by this author on:
C Mecucci,
C Mecucci
Center for Human Genetics, University of Leuven, Belgium.
Search for other works by this author on:
P Marynen,
P Marynen
Center for Human Genetics, University of Leuven, Belgium.
Search for other works by this author on:
C Guo,
C Guo
Center for Human Genetics, University of Leuven, Belgium.
Search for other works by this author on:
D Franckx,
D Franckx
Center for Human Genetics, University of Leuven, Belgium.
Search for other works by this author on:
R La Starza,
R La Starza
Center for Human Genetics, University of Leuven, Belgium.
Search for other works by this author on:
A Aventin,
A Aventin
Center for Human Genetics, University of Leuven, Belgium.
Search for other works by this author on:
A Bosly,
A Bosly
Center for Human Genetics, University of Leuven, Belgium.
Search for other works by this author on:
MF Martelli,
MF Martelli
Center for Human Genetics, University of Leuven, Belgium.
Search for other works by this author on:
JJ Cassiman
JJ Cassiman
Center for Human Genetics, University of Leuven, Belgium.
Search for other works by this author on:
Blood (1995) 85 (10): 2848–2852.
Citation
I Wlodarska, C Mecucci, P Marynen, C Guo, D Franckx, R La Starza, A Aventin, A Bosly, MF Martelli, JJ Cassiman; TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13). Blood 1995; 85 (10): 2848–2852. doi: https://doi.org/10.1182/blood.V85.10.2848.bloodjournal85102848
Download citation file:
May 1 1995
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal